Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients

NCT03089970 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT03089970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03089970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients
Lead sponsor
University of California, Davis
Phase
Observational
Overall status
Completed
Start date
February 1, 2017
Completion date
September 1, 2020
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

upper respiratory tract infections, asthma, exhaled breath